UBS Global criticizes proposed Mylan-King deal WASHINGTON An investment firm has told Mylan Laboratories that a proposed acquisition of King Pharmaceuticals is not in the best interests of investors. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 